Medicare Enrolled
Dr. Joel Lattin, D.O.
Gastroenterology · Arlington Heights, IL
Practice pattern: Mixed Practice
— Diverse clinical practice across multiple procedure types
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Lattin from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Lattin?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Lattin
Dr. Joel Lattin is a gastroenterology specialist in Arlington Heights, IL, with 20 years of NPI registration. Based on federal Medicare data, Dr. Lattin performed 8,549 Medicare services in 2023. These records do not provide a deduplicated patient total.
Between the years covered by Open Payments, Dr. Lattin received a total of $6,641 from 35 pharmaceutical and/or device companies across 332 payment records. A record can group multiple payments. These transfers are publicly reported through CMS Open Payments. Disclosure alone does not establish their effect on care. A reliable breakdown by payment category is not available in this snapshot. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Lattin is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 20 years of NPI registration
▲ Top 2% volume in IL
$6,641 industry payments
Medicare Practice Summary — 2023
Medicare Utilization ↗8,549
Medicare services
Top 2% in IL for gastroenterology
Not available
Unique patients (not deduplicated)
$28
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Vedolizumab infusion (Entyvio) This procedure involves the administration of vedolizumab via injection. The dosage is measured in milligrams. |
5,700 | $17 | $50 |
| Infliximab infusion (Remicade) An injection of infliximab, excluding biosimilar versions, administered in a 10 mg dose. |
1,900 | $24 | $150 |
| Colonoscopy with biopsy A procedure to collect tissue samples from the large intestine using a flexible tube with a camera. The samples are examined to check for abnormalities or disease. |
155 | $105 | $1,245 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
128 | $95 | $212 |
| Hospital follow-up visit, moderate complexity Follow-up hospital visit for an existing patient involving moderate medical decision making. The visit requires at least 35 minutes of time spent on the date of service. |
123 | $66 | $200 |
| Colon polyp removal with endoscopic snare This procedure removes polyps or growths from the large bowel using a flexible tube with a camera and a wire loop tool. The snare is used to cut off the growths during the examination. |
95 | $223 | $1,425 |
| Upper GI endoscopy with biopsy A procedure to collect tissue samples from the esophagus, stomach, or upper small intestine using a flexible tube with a camera. The samples are examined to check for abnormalities. |
89 | $74 | $925 |
| Hospital follow-up visit, low complexity Follow-up hospital visit for an established patient with straightforward or low-level medical decision making. The visit requires at least 25 minutes of time spent on the day of service. |
77 | $41 | $150 |
| Initial hospital admission, moderate complexity Initial hospital inpatient or observation care for a new patient involving moderate-level medical decision making, with at least 55 minutes total time on the date of the encounter. |
61 | $109 | $300 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
52 | $115 | $328 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
34 | $59 | $150 |
| Additional hour of intravenous chemotherapy This code represents the administration of chemotherapy medication into a vein for each additional hour beyond the initial period. |
28 | $22 | $250 |
| Intravenous chemotherapy infusion, 1 hour or less Administration of chemotherapy medication directly into a vein. The procedure takes one hour or less to complete. |
27 | $99 | $390 |
| Initial hospital admission, high complexity Initial hospital inpatient or observation care for a new patient involving high-level medical decision making, with at least 75 minutes total time on the date of the encounter. |
20 | $133 | $407 |
| Intravenous infusion, 1 hour or less Administration of medication or fluid directly into a vein for therapeutic, preventive, or diagnostic purposes. The procedure lasts one hour or less. |
19 | $53 | $146 |
| Colonoscopy for colorectal cancer screening, high risk A colonoscopy performed to screen for colorectal cancer in individuals identified as being at high risk for the disease. |
19 | $196 | $1,434 |
| Colonoscopy A diagnostic exam of the large bowel using a flexible endoscope to visualize the interior of the colon. |
11 | $143 | $1,190 |
| Colonoscopy for colorectal cancer screening A colonoscopy performed to screen for colorectal cancer in individuals who are not at high risk for the disease. |
11 | $174 | $1,315 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. These counts do not measure clinical quality or years of experience.
89.4% high complexity
3.7% medium
6.9% routine
Industry Payment Transparency
Open Payments through 2024 ↗$6,641
Total received (2018-2024)
Avg $949/year across 7 years
Top 23% in IL for gastroenterology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
35
Companies
332
Payment records
Payments are publicly reported; disclosure does not establish legality · Not evidence of wrongdoing · How to interpret →
Payment categories are unavailable while the source breakdown is being rebuilt. Company and year totals do not identify how much belongs to each category.
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$2,088
2023
$1,856
2022
$798
2021
$574
2020
$213
2019
$674
2018
$440
Payments by company (2024)
Janssen Biotech, Inc.
$715
ABBVIE INC.
$477
Takeda Pharmaceuticals U.S.A., Inc.
$164
PFIZER INC.
$139
Gilead Sciences, Inc.
$109
Salix Pharmaceuticals, a division of Bausch Health US, LLC
$85
GENZYME CORPORATION
$59
Phathom Pharmaceuticals, Inc.
$59
IRONWOOD PHARMACEUTICALS, INC
$51
Lilly USA, LLC
$45
Celgene Corporation
$44
Madrigal Pharmaceuticals
$25
Ferring Pharmaceuticals Inc.
$24
Ipsen Biopharmaceuticals, Inc
$22
QOL Medical, LLC
$20
Ardelyx, Inc.
$18
EVOKE PHARMA, INC.
$17
Intercept Pharmaceuticals, Inc.
$14
Top 3 companies account for 65.0% of 2024 payments
All-time payments by company (2018-2024) ›
Janssen Biotech, Inc.
$1,914
ABBVIE INC.
$964
Gilead Sciences, Inc.
$701
Takeda Pharmaceuticals U.S.A., Inc.
$598
Salix Pharmaceuticals, a division of Bausch Health US, LLC
$349
PFIZER INC.
$246
AbbVie, Inc.
$173
Allergan Inc.
$166
UCB, Inc.
$150
Celgene Corporation
$147
Regeneron Healthcare Solutions, Inc.
$135
QOL Medical, LLC
$98
GENZYME CORPORATION
$88
AbbVie Inc.
$83
Intercept Pharmaceuticals, Inc.
$82
Braintree Laboratories, Inc.
$71
Ardelyx, Inc.
$68
Allergan, Inc.
$60
Phathom Pharmaceuticals, Inc.
$59
Ferring Pharmaceuticals Inc.
$56
IRONWOOD PHARMACEUTICALS, INC
$51
Ironwood Pharmaceuticals, Inc
$46
Lilly USA, LLC
$45
Organon LLC
$42
W. L. Gore & Associates, Inc.
$39
VIVUS LLC
$25
Madrigal Pharmaceuticals
$25
Amgen Inc.
$24
Romark Laboratories, LC
$23
Concordia Pharmaceuticals Inc.
$23
Shire North American Group Inc
$22
Ipsen Biopharmaceuticals, Inc
$22
EVOKE PHARMA, INC.
$17
Merck Sharp & Dohme Corporation
$14
Synergy Pharmaceuticals Inc
$14
Top 3 companies account for 53.9% of all-time payments
Associated products mentioned in payments ›
AVSOLA · Alinia · Amitiza · CIMZIA · CREON · Cimzia · Creon · DUPIXENT · Donnatal · ENTYVIO · Entyvio · Epclusa · GATTEX · GIMOTI · GORE CARDIOFORM Septal Occluder · HUMIRA · Humira · IBSRELA · IQIRVO · LINZESS · Linzess · MAVYRET · Mavyret · OCALIVA · OMVOH · QSYMIA · Qsymia · REBYOTA · REMICADE · RENFLEXIS · RESMETIROM · RINVOQ · SKYRIZI · STELARA · SUCRAID · SUPREP · SUPREP BOWEL PREP · SUTAB · Sucraid · TREMFYA · TRULANCE · Trulance · VIBERZI · VOQUEZNA · XELJANZ · XIFAXAN · XIFAXANIBSD · XIFIXAN · ZENPEP · ZEPATIER · ZEPOSIA
Should you be concerned? Industry payments are disclosed through CMS Open Payments. Disclosure alone does not establish their purpose, legality, or effect on care. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Geographic Context
Gastroenterologists in nearby ZIP areas
410
County median income
$81,797
Nearest hospital to ZIP centroid (approximate)
NORTHWEST COMMUNITY HOSPITAL 1
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | NPPES snapshot; verify current record |
| Medicare Enrollment | ✓ PECOS | PECOS snapshot |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not included | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Lattin is a mixed practice specialist, with above-average Medicare volume (top 2% in IL), with 20 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Lattin experienced with vedolizumab infusion (entyvio)?
Based on Medicare claims data, Dr. Lattin performed 5,700 vedolizumab infusion (entyvio) services. These records cover Medicare fee-for-service activity, including eligible younger beneficiaries; they do not measure total practice volume or clinical quality.
Does Dr. Lattin receive payments from pharmaceutical companies?
Yes. Dr. Lattin received a total of $6,641 from 35 companies across 332 payment records. A record can group multiple payments. These transfers are publicly disclosed through CMS Open Payments. Disclosure alone does not establish their legality or effect on care. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Lattin's costs compare to other gastroenterologists in Arlington Heights?
Dr. Lattin's average Medicare payment per service is $28. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Lattin) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating the presence of registry, enrollment, activity or payment records, not verified experience or clinical quality. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Source publication dates and the snapshots loaded on this site can differ. Rebuilding a page does not refresh its source records. Check the Medicare reporting year and the payment interval shown above; consult the linked official sources for newer releases and current registry details. See our data freshness policy →
Explore related providers
Specialty guide
Understanding Gastroenterology
Common procedures, typical costs, and what industry payments mean in gastroenterology.
Same specialty & city
Gastroenterologists in Arlington Heights
Browse gastroenterologists in Arlington Heights ranked by procedure volume and transparency data.
Highest volume
Top Gastroenterologists in IL
Gastroenterologists ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Gastroenterologists in IL
Which IL gastroenterologists receive the most from drug and device companies.
By company
Janssen Biotech, Inc. Payments to Doctors
See all physicians who received payments from Janssen Biotech, Inc.
By company
ABBVIE INC. Payments to Doctors
See all physicians who received payments from ABBVIE INC.
By company
Gilead Sciences, Inc. Payments to Doctors
See all physicians who received payments from Gilead Sciences, Inc.
About this page
This page combines public CMS records with calculated summaries and explanatory procedure labels. These transformations are not verbatim federal records. Sources: NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology